RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms
Go back to RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms| Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) | Delayed: 5.57 -0.15 (2.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.72 | 52 Week High | $5.95 | |||
| Open | $5.76 | 52 Week Low | $4.20 | |||
| Day High | $5.91 | P/E | 92.83 | |||
| Day Low | $5.55 | EPS | $0.06 | |||
| Volume | 50,301 | |||||
| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.84 +0.03 (3.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.81 | 52 Week High | $16.54 | |||
| Open | $0.83 | 52 Week Low | $8.10 | |||
| Day High | $0.87 | P/E | N/A | |||
| Day Low | $0.81 | EPS | $0.00 | |||
| Volume | 161,590 | |||||
